• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰老细胞清除药物的研发策略。

Strategies for senolytic drug discovery.

机构信息

Faculty of Engineering, School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, New South Wales, Australia.

Centre for Advanced Food Engineering, The University of Sydney, Sydney, New South Wales, Australia.

出版信息

Aging Cell. 2023 Oct;22(10):e13948. doi: 10.1111/acel.13948. Epub 2023 Aug 7.

DOI:10.1111/acel.13948
PMID:37548098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10577556/
Abstract

Senolytics are a category of drugs that reduce the impact of cellular senescence, an effect associated with a range of chronic and age-related diseases. Since the discovery of the first senolytics in 2015, the number of known senolytic agents has grown dramatically. This review discusses the broad categories of known senolytics-kinase inhibitors, Bcl-2 family protein inhibitors, naturally occurring polyphenols, heat shock protein inhibitors, BET family protein inhibitors, P53 stabilizers, repurposed anti-cancer drugs, cardiac steroids, PPAR-alpha agonists, and antibiotics. The approaches used to screen for new senolytics are articulated including a range of methods to induce senescence, different target cell types, various senolytic assays, and markers. The choice of methods can greatly influence the outcomes of a screen, with high-quality screens featuring robust systems, adequate controls, and extensive validation in alternate assays. Recent advances in single-cell analysis and computational methods for senolytic identification are also discussed. There is significant potential for further drug discovery, but this will require additional research into drug targets and mechanisms of actions and their subsequent rigorous evaluation in pre-clinical models and human trials.

摘要

衰老细胞清除剂是一类能够减轻细胞衰老影响的药物,细胞衰老是与一系列慢性和与年龄相关的疾病相关的效应。自 2015 年首次发现衰老细胞清除剂以来,已知的衰老细胞清除剂的数量显著增加。这篇综述讨论了已知的衰老细胞清除剂的广泛类别,包括:激酶抑制剂、Bcl-2 家族蛋白抑制剂、天然存在的多酚、热休克蛋白抑制剂、BET 家族蛋白抑制剂、P53 稳定剂、再利用的抗癌药物、心脏甾体、PPAR-α 激动剂和抗生素。本文还阐述了用于筛选新的衰老细胞清除剂的方法,包括诱导衰老的一系列方法、不同的靶细胞类型、各种衰老细胞清除剂检测和标记物。方法的选择会极大地影响筛选的结果,高质量的筛选需要具有强大系统、充分对照和在其他检测中的广泛验证的方法。本文还讨论了衰老细胞清除剂鉴定中单细胞分析和计算方法的最新进展。进一步的药物发现具有巨大的潜力,但这需要对药物靶点和作用机制进行更多的研究,并在临床前模型和人体试验中对其进行严格的评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f6/10577556/efda368c3ff5/ACEL-22-e13948-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f6/10577556/1898510ba5f7/ACEL-22-e13948-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f6/10577556/5846328fd235/ACEL-22-e13948-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f6/10577556/7452b2e3b6cf/ACEL-22-e13948-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f6/10577556/efda368c3ff5/ACEL-22-e13948-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f6/10577556/1898510ba5f7/ACEL-22-e13948-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f6/10577556/5846328fd235/ACEL-22-e13948-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f6/10577556/7452b2e3b6cf/ACEL-22-e13948-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f6/10577556/efda368c3ff5/ACEL-22-e13948-g005.jpg

相似文献

1
Strategies for senolytic drug discovery.衰老细胞清除药物的研发策略。
Aging Cell. 2023 Oct;22(10):e13948. doi: 10.1111/acel.13948. Epub 2023 Aug 7.
2
Characterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic.CUDC-907 作为一种新型的衰老细胞选择性抑制剂的特征。
Aging (Albany NY). 2023 Mar 28;15(7):2373-2394. doi: 10.18632/aging.204616.
3
Discovering small-molecule senolytics with deep neural networks.利用深度神经网络发现小分子衰老细胞清除剂。
Nat Aging. 2023 Jun;3(6):734-750. doi: 10.1038/s43587-023-00415-z. Epub 2023 May 4.
4
Recent advances in the discovery of senolytics.衰老细胞清除剂的最新发现进展。
Mech Ageing Dev. 2021 Dec;200:111587. doi: 10.1016/j.mad.2021.111587. Epub 2021 Oct 14.
5
From the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs.从衰老细胞命运的分歧到衰老细胞选择性清除药物的作用机制。
Open Biol. 2022 Sep;12(9):220171. doi: 10.1098/rsob.220171. Epub 2022 Sep 21.
6
Recent Advances in Senotherapeutics Delivery.衰老治疗递送的最新进展
Tissue Eng Part B Rev. 2022 Dec;28(6):1223-1234. doi: 10.1089/ten.TEB.2021.0212. Epub 2022 Jul 12.
7
Senotherapeutics for mesenchymal stem cell senescence and rejuvenation.用于间充质干细胞衰老与年轻化的衰老疗法。
Drug Discov Today. 2023 Jan;28(1):103424. doi: 10.1016/j.drudis.2022.103424. Epub 2022 Nov 1.
8
Discovery of senolytics using machine learning.使用机器学习发现衰老细胞清除剂。
Nat Commun. 2023 Jun 10;14(1):3445. doi: 10.1038/s41467-023-39120-1.
9
Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice.短期清除或稳定干预可挽救辐射诱导的虚弱和早衰在小鼠中的进展。
Elife. 2022 May 4;11:e75492. doi: 10.7554/eLife.75492.
10
Recent update on discovery and development of Hsp90 inhibitors as senolytic agents.最近关于 HSP90 抑制剂作为衰老细胞溶解剂的发现和开发的最新进展。
Int J Biol Macromol. 2020 Oct 15;161:1086-1098. doi: 10.1016/j.ijbiomac.2020.06.115. Epub 2020 Jun 16.

引用本文的文献

1
Development and Application of a Senolytic Predictor for Discovery of Novel Senolytic Compounds and Herbs.用于发现新型衰老细胞裂解化合物和草药的衰老细胞裂解预测器的开发与应用
Molecules. 2025 Jun 19;30(12):2653. doi: 10.3390/molecules30122653.
2
Single-cell morphology encodes functional subtypes of senescence in aging human dermal fibroblasts.单细胞形态编码衰老人类皮肤成纤维细胞衰老的功能亚型。
Sci Adv. 2025 Apr 25;11(17):eads1875. doi: 10.1126/sciadv.ads1875.
3
ITGA1, the alpha 1 subunit of integrin receptor, is a novel marker of drug-resistant senescent melanoma cells in vitro.

本文引用的文献

1
Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice.衰老细胞溶解疫苗接种可改善正常和病理性衰老相关表型,并延长早衰小鼠的寿命。
Nat Aging. 2021 Dec;1(12):1117-1126. doi: 10.1038/s43587-021-00151-2. Epub 2021 Dec 10.
2
A focused natural compound screen reveals senolytic and senostatic effects of .一项针对性的天然化合物筛选揭示了……的促衰老细胞溶解和衰老抑制作用。 (注:原文句末不完整,缺少具体所指物质)
Anim Cells Syst (Seoul). 2022 Nov 11;26(6):310-317. doi: 10.1080/19768354.2022.2143895. eCollection 2022.
3
Targeting Multiple Homeostasis-Maintaining Systems by Ionophore Nigericin Is a Novel Approach for Senolysis.
整合素受体的α1亚基ITGA1是体外耐药衰老黑素瘤细胞的一种新型标志物。
Arch Toxicol. 2025 Apr 9. doi: 10.1007/s00204-025-04028-w.
4
Fisetin ameliorates vascular smooth muscle cell calcification via DUSP1-dependent p38 MAPK inhibition.漆黄素通过依赖双特异性磷酸酶1的p38丝裂原活化蛋白激酶抑制作用改善血管平滑肌细胞钙化。
Aging (Albany NY). 2025 Apr 2;17(4):885-907. doi: 10.18632/aging.206233.
5
Pathological and Inflammatory Consequences of Aging.衰老的病理和炎症后果
Biomolecules. 2025 Mar 12;15(3):404. doi: 10.3390/biom15030404.
6
Prognostic impact of a senescence gene signature in multiple myeloma.衰老基因特征在多发性骨髓瘤中的预后影响
Geroscience. 2025 Mar 25. doi: 10.1007/s11357-025-01622-9.
7
Hydrogen Peroxide-Releasing Hydrogel-Mediated Cellular Senescence Model for Aging Research.用于衰老研究的过氧化氢释放水凝胶介导的细胞衰老模型
Biomater Res. 2025 Mar 14;29:0161. doi: 10.34133/bmr.0161. eCollection 2025.
8
Natural Product-Derived Senotherapeutics: Extraction and Biological Evaluation Techniques.天然产物衍生的衰老疗法:提取与生物学评估技术
Methods Mol Biol. 2025;2906:315-359. doi: 10.1007/978-1-0716-4426-3_19.
9
Immunosenescence promotes cancer development: from mechanisms to treatment strategies.免疫衰老促进癌症发展:从机制到治疗策略。
Cell Commun Signal. 2025 Mar 10;23(1):128. doi: 10.1186/s12964-025-02082-6.
10
Targeting p21-Positive Senescent Chondrocytes via IL-6R/JAK2 Inhibition to Alleviate Osteoarthritis.通过抑制IL-6R/JAK2靶向p21阳性衰老软骨细胞以减轻骨关节炎
Adv Sci (Weinh). 2025 Mar;12(11):e2410795. doi: 10.1002/advs.202410795. Epub 2025 Jan 23.
Nigericin 通过靶向多种维持内稳态的系统来实现衰老细胞选择性清除是一种新的策略。
Int J Mol Sci. 2022 Nov 17;23(22):14251. doi: 10.3390/ijms232214251.
4
Nintedanib induces senolytic effect via STAT3 inhibition.尼达尼布通过抑制 STAT3 诱导衰老细胞溶解。
Cell Death Dis. 2022 Sep 2;13(9):760. doi: 10.1038/s41419-022-05207-8.
5
The promising potential of piperlongumine as an emerging therapeutics for cancer.荜茇明作为一种新兴的癌症治疗药物具有广阔的潜力。
Explor Target Antitumor Ther. 2021;2(4):323-354. doi: 10.37349/etat.2021.00049. Epub 2021 Aug 30.
6
Cellular senescence and senolytics: the path to the clinic.细胞衰老与衰老细胞清除:通往临床的道路。
Nat Med. 2022 Aug;28(8):1556-1568. doi: 10.1038/s41591-022-01923-y. Epub 2022 Aug 11.
7
Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice.药物性衰老细胞清除减轻蒽环类药物诱导的心肌毒性并改善小鼠心功能。
Pharmacol Res. 2022 Sep;183:106356. doi: 10.1016/j.phrs.2022.106356. Epub 2022 Jul 14.
8
Aging, Senescence, and Dementia.衰老、衰老和痴呆。
J Prev Alzheimers Dis. 2022;9(3):523-531. doi: 10.14283/jpad.2022.42.
9
Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer.单细胞转录组学鉴定出 Mcl-1 是癌症衰老治疗的靶点。
Nat Commun. 2022 Apr 21;13(1):2177. doi: 10.1038/s41467-022-29824-1.
10
Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.糖尿病中的细胞衰老:脂肪组织和胰腺 β 细胞的独特衰老治疗策略。
Front Endocrinol (Lausanne). 2022 Mar 31;13:869414. doi: 10.3389/fendo.2022.869414. eCollection 2022.